Imexpharm (STC:IMP) Other Gross PPE: ₫48,010 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STC:IMP Imexpharm Corp STC:IMP
98 GF Score
Price ₫39,800.00
GF Value ₫48,932.29
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Imexpharm Other Gross PPE?

Imexpharm STC:IMP 98 Other Gross PPE is ₫48,010 Mil as of Jun. 2026. GuruFocus rates STC:IMP with a GF Score™ of 98/100 and a GF Value™ of ₫48,932.29 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Imexpharm's Other Gross PPE for the quarter that ended in Jun. 2026 was ₫48,010 Mil.

Imexpharm's quarterly Other Gross PPE increased from Dec. 2025 (₫45,680 Mil) to Mar. 2026 (₫46,988 Mil) and increased from Mar. 2026 (₫46,988 Mil) to Jun. 2026 (₫48,010 Mil).

Imexpharm's annual Other Gross PPE declined from Dec. 2023 (₫50,086 Mil) to Dec. 2024 (₫47,720 Mil) and declined from Dec. 2024 (₫47,720 Mil) to Dec. 2025 (₫45,680 Mil).

Imexpharm Other Gross PPE Historical Data

* Premium members only.

The historical data trend for Imexpharm's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imexpharm Other Gross PPE Chart

Imexpharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44,210.59 46,910.91 50,085.99 47,719.83 45,680.15

Imexpharm Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47,801.40 49,568.55 45,680.15 46,988.13 48,010.02
STC:IMP
98GF Score
Imexpharm Corp STC:IMP
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imexpharm Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of ₫48,010 Mil mean?
Imexpharm (STC:IMP) has a Other Gross PPE of ₫48,010 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Imexpharm and its competitors.
Is Imexpharm's Other Gross PPE too high?
Imexpharm's current Other Gross PPE is ₫48,010 Mil. Overall, Imexpharm has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imexpharm's Other Gross PPE compare to ZTS?
Imexpharm's Other Gross PPE of ₫48,010 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Drug Manufacturers company?
A good Other Gross PPE depends on the Drug Manufacturers industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Imexpharm and its competitors. Imexpharm's current Other Gross PPE is ₫48,010 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imexpharm stock overvalued right now?
Based on GuruFocus' analysis, Imexpharm (STC:IMP) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫48,932.29, compared to a current price of ₫39,800.00 — trading 18.7% below its estimated fair value. The current Other Gross PPE is ₫48,010 Mil. Imexpharm's overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For Imexpharm (STC:IMP), the current Other Gross PPE is ₫48,010 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imexpharm (STC:IMP) Overvalued in 2026?

Based on GuruFocus' analysis, Imexpharm stock appears to be undervalued. The current stock price of ₫39,800.00 is trading 18.7% below its estimated GF Value™ of ₫48,932.29. GuruFocus considers Imexpharm to be Modestly Undervalued.

Key valuation signals for STC:IMP:

  • Other Gross PPE: ₫48,010 Mil
  • GF Value™: ₫48,932.29 vs. price of ₫39,800.00 (18.7% below fair value)
  • GF Score™: 98/100 with 1 warning sign

No single metric tells the full story. See the STC:IMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imexpharm Business Description

Address 4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. The company's products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.
98GF Score

Get the complete analysis for STC:IMP

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫39,800.00
Price
₫48,932.29
GF Value